If you have a history of breast cancer and a mutation in an inherited breast cancer gene (i.e., BRCA1/2, PALB2, ATM, or CHEK2), you may be eligible to contribute to tumor genomics studies that are being conducted through the Inherited Cancer Registry (ICARE). Through this effort, we are researching: - breast cancer characteristics - factors associated with outcomes, including treatments - studying genomics of the tumors to better understand pathways to tumor development, which can hopefully lead

If you have a history of breast cancer and a mutation in the CHEK2...